WHO WE SERVE / CONTRACT RESEARCH ORGANIZATIONS

The RBQM Platform for CROs That Compete on Quality

Sponsors no longer evaluate CROs on monitoring volume alone. They want to understand how risks were prioritized, how oversight was applied, and whether decisions are defensible under ICH E6(R3). CROs that can demonstrate a standardized, scalable Risk-Based Quality Management (RBQM) operating model win more studies, protect margins, and build the kind of sponsor confidence that turns one contract into a long-term partnership. CluePoints is the execution platform that makes that model repeatable, inspection-defensible, and scalable.

Top 20

global pharma companies use CluePoints

500+

enterprise studies actively monitored

40%

reduction in
monitoring costs

3x

faster risk signal identification

Challenges We Solve for Global CROs

CRO leadership faces mounting pressure to protect margin, win differentiated work, and demonstrate defensible oversight at scale. CluePoints is built for this operating model.

Sponsors Demanding Defensible, 
Risk-Proportionate Oversight

Sponsors increasingly require CROs to explain why monitoring intensity was set as it was, with a traceable, risk-proportionate oversight record they can present to regulators. CROs without a standardized RBQM execution platform struggle to provide this. CluePoints enables CROs to operationalize regulatory-grade RBQM with full CtQ alignment, centralized monitoring, prioritized site-level action, and inspection-ready documentation, making the oversight narrative defensible at every level and stage.

Margin Erosion from Legacy Monitoring Models

Heavy on-site visit schedules, a high Source Data Verification (SDV) burden, and linear headcount scaling create structural margin pressure that discounting cannot solve in the long term. RBQM-enabled monitoring models reduce low-value on-site visits by 30–50%, target SDV and Source Data Review (SDR) based on actual risk, and concentrate CRA time on high-risk sites and critical data, protecting study-level margin without compromising quality or regulatory defensibility.

Commercial Promise vs. Operational Reality

CRO sales teams increasingly propose adaptive monitoring and risk-based approaches in requests for proposals (RFPs). Operations teams may lack the standardized frameworks, execution guardrails, and documented traceability to back up those promises. CluePoints closes the gap with RBQM deployment playbooks, governance frameworks, and signal-to-action documentation that makes the commercial narrative operationally defensible, reducing audit vulnerability and protecting renewal conversations.

Fragmented Technology Across Functions

When central monitoring, quality assurance, Data Management (DM), and clinical operations operate from different tools and data sources, RBQM cannot scale consistently. CluePoints provides a unified RBQM intelligence layer with cross-functional analytics, integrated signal-to-action workflows, and standardized execution that works across FSO and FSP models, eliminating the silos that undermine sponsor confidence and operational quality.

 

The Complete Clinical Intelligence Platform for CROs

A vendor-agnostic, unified RBQM and clinical data quality platform that scales with your sponsor portfolio.

Let's Discuss Your CRO's RBQM Strategy

Our CRO specialists are ready to walk you through how CluePoints fits your operating model and your sponsor relationships.